{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:18:06Z","timestamp":1780514286181,"version":"3.54.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T00:00:00Z","timestamp":1542412800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T00:00:00Z","timestamp":1542412800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA033930"],"award-info":[{"award-number":["DA033930"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR067738"],"award-info":[{"award-number":["AR067738"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00213-018-5103-5","type":"journal-article","created":{"date-parts":[[2018,11,17]],"date-time":"2018-11-17T18:29:57Z","timestamp":1542479397000},"page":"973-988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Using Ca2+-channel biosensors to profile amphetamines and cathinones at monoamine transporters: electro-engineering cells to detect potential new psychoactive substances"],"prefix":"10.1007","volume":"236","author":[{"given":"Tyler W. E.","family":"Steele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5288-1669","authenticated-orcid":false,"given":"Jose M.","family":"Eltit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,17]]},"reference":[{"key":"5103_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/7854_2016_54","volume":"32","author":"SM Aarde","year":"2017","unstructured":"Aarde SM, Taffe MA (2017) Predicting the abuse liability of entactogen-class, new and emerging psychoactive substances via preclinical models of drug self-administration. Curr Top Behav Neurosci 32:145\u2013164","journal-title":"Curr Top Behav Neurosci"},{"key":"5103_CR2","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1016\/S0006-3495(02)75328-9","volume":"83","author":"SV Adams","year":"2002","unstructured":"Adams SV, DeFelice LJ (2002) Flux coupling in the human serotonin transporter. Biophys J 83:3268\u20133282","journal-title":"Biophys J"},{"key":"5103_CR3","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/S0006-3495(03)74587-1","volume":"85","author":"SV Adams","year":"2003","unstructured":"Adams SV, DeFelice LJ (2003) Ionic currents in the human serotonin transporter reveal inconsistencies in the alternating access hypothesis. Biophys J 85:1548\u20131559","journal-title":"Biophys J"},{"key":"5103_CR4","doi-asserted-by":"publisher","first-page":"8370","DOI":"10.1523\/JNEUROSCI.22-19-08370.2002","volume":"22","author":"A Androutsellis-Theotokis","year":"2002","unstructured":"Androutsellis-Theotokis A, Rudnick G (2002) Accessibility and conformational coupling in serotonin transporter predicted internal domains. J Neurosci 22:8370\u20138378","journal-title":"J Neurosci"},{"key":"5103_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s40501-015-0042-9","volume":"2","author":"ML Banks","year":"2015","unstructured":"Banks ML, Hutsell BA, Schwienteck KL, Negus SS (2015) Use of preclinical drug vs. food choice procedures to evaluate candidate medications for cocaine addiction. Curr Treat Options Psychiatry 2:136\u2013150","journal-title":"Curr Treat Options Psychiatry"},{"key":"5103_CR6","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1021\/acschemneuro.8b00138","volume":"9","author":"UM Battisti","year":"2018","unstructured":"Battisti UM, Sitta R, Harris A, Sakloth F, Walther D, Ruchala I, Negus S, Baumann MH, Glennon RA, Eltit JM (2018) Effects of N-alkyl-4-methylamphetamine optical isomers on plasma membrane monoamine transporters and abuse-related behavior. ACS Chem Neurosci 9:1829\u20131839","journal-title":"ACS Chem Neurosci"},{"key":"5103_CR7","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.1476-5381.2012.02214.x","volume":"168","author":"CT Bauer","year":"2013","unstructured":"Bauer CT, Banks ML, Blough BE, Negus SS (2013) Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats. Br J Pharmacol 168:850\u2013862","journal-title":"Br J Pharmacol"},{"key":"5103_CR8","unstructured":"Baumann MH (2016) The changing face of recreational drug use. Cerebrum 2016 cer-01-16"},{"key":"5103_CR9","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1124\/jpet.110.176271","volume":"337","author":"MH Baumann","year":"2011","unstructured":"Baumann MH, Clark RD, Woolverton WL, Wee S, Blough BE, Rothman RB (2011) In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the rat. J Pharmacol Exp Ther 337:218\u2013225","journal-title":"J Pharmacol Exp Ther"},{"key":"5103_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2012.11.020","volume":"698","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR (2013a) Psychoactive \u201cbath salts\u201d: not so soothing. Eur J Pharmacol 698:1\u20135","journal-title":"Eur J Pharmacol"},{"key":"5103_CR11","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/npp.2012.204","volume":"38","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, Rothman RB, Goldberg SR, Lupica CR, Sitte HH, Brandt SD, Tella SR, Cozzi NV, Schindler CW (2013b) Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products. Neuropsychopharmacology 38:552\u2013562","journal-title":"Neuropsychopharmacology"},{"key":"5103_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ceca.2006.09.002","volume":"40","author":"MJ Berridge","year":"2006","unstructured":"Berridge MJ (2006) Calcium microdomains: organization and function. Cell Calcium 40:405\u2013412","journal-title":"Cell Calcium"},{"key":"5103_CR13","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nrm1155","volume":"4","author":"MJ Berridge","year":"2003","unstructured":"Berridge MJ, Bootman MD, Roderick HL (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4:517\u2013529","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5103_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1021\/ml500113s","volume":"5","author":"BE Blough","year":"2014","unstructured":"Blough BE, Landavazo A, Partilla JS, Baumann MH, Decker AM, Page KM, Rothman RB (2014) Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeutics. ACS Med Chem Lett 5:623\u2013627","journal-title":"ACS Med Chem Lett"},{"key":"5103_CR15","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1111\/bph.13030","volume":"172","author":"JS Bonano","year":"2015","unstructured":"Bonano JS, Banks ML, Kolanos R, Sakloth F, Barnier ML, Glennon RA, Cozzi NV, Partilla JS, Baumann MH, Negus SS (2015) Quantitative structure-activity relationship analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172:2433\u20132444","journal-title":"Br J Pharmacol"},{"key":"5103_CR16","doi-asserted-by":"publisher","first-page":"25764","DOI":"10.1074\/jbc.M114.574269","volume":"289","author":"L Borre","year":"2014","unstructured":"Borre L, Andreassen TF, Shi L, Weinstein H, Gether U (2014) The second sodium site in the dopamine transporter controls cation permeation and is regulated by chloride. J Biol Chem 289:25764\u201325773","journal-title":"J Biol Chem"},{"key":"5103_CR17","first-page":"320","volume":"27","author":"OJ Braenden","year":"1979","unstructured":"Braenden OJ (1979) Research on the chemical composition of khat. NIDA Res Monogr 27:320\u2013321","journal-title":"NIDA Res Monogr"},{"key":"5103_CR18","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1152\/jn.00094.2012","volume":"108","author":"SY Branch","year":"2012","unstructured":"Branch SY, Beckstead MJ (2012) Methamphetamine produces bidirectional, concentration-dependent effects on dopamine neuron excitability and dopamine-mediated synaptic currents. J Neurophysiol 108:802\u2013809","journal-title":"J Neurophysiol"},{"key":"5103_CR19","doi-asserted-by":"publisher","first-page":"a004168","DOI":"10.1101\/cshperspect.a004168","volume":"3","author":"M Brini","year":"2011","unstructured":"Brini M, Carafoli E (2011) The plasma membrane Ca(2)+ ATPase and the plasma membrane sodium calcium exchanger cooperate in the regulation of cell calcium. Cold Spring Harb Perspect Biol 3:a004168","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5103_CR20","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1111\/bph.12061","volume":"168","author":"KN Cameron","year":"2013","unstructured":"Cameron KN, Kolanos R, Solis E Jr, Glennon RA, De Felice LJ (2013) Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter. Br J Pharmacol 168:1750\u20131757","journal-title":"Br J Pharmacol"},{"key":"5103_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ceca.2015.06.013","volume":"58","author":"KN Cameron","year":"2015","unstructured":"Cameron KN, Solis E Jr, Ruchala I, De Felice LJ, Eltit JM (2015) Amphetamine activates calcium channels through dopamine transporter-mediated depolarization. Cell Calcium 58:457\u2013466","journal-title":"Cell Calcium"},{"key":"5103_CR22","doi-asserted-by":"publisher","first-page":"16046","DOI":"10.1073\/pnas.0403299101","volume":"101","author":"L Carvelli","year":"2004","unstructured":"Carvelli L, McDonald PW, Blakely RD, DeFelice LJ (2004) Dopamine transporters depolarize neurons by a channel mechanism. Proc Natl Acad Sci U S A 101:16046\u201316051","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5103_CR23","doi-asserted-by":"publisher","first-page":"a003947","DOI":"10.1101\/cshperspect.a003947","volume":"3","author":"WA Catterall","year":"2011","unstructured":"Catterall WA (2011) Voltage-gated calcium channels. Cold Spring Harb Perspect Biol 3:a003947","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5103_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1124\/pr.57.4.5","volume":"57","author":"WA Catterall","year":"2005","unstructured":"Catterall WA, Perez-Reyes E, Snutch TP, Striessnig J (2005) International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57:411\u2013425","journal-title":"Pharmacol Rev"},{"key":"5103_CR25","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0091-3057(97)00323-7","volume":"58","author":"TA Dal Cason","year":"1997","unstructured":"Dal Cason TA, Young R, Glennon RA (1997) Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs. Pharmacol Biochem Behav 58:1109\u20131116","journal-title":"Pharmacol Biochem Behav"},{"key":"5103_CR26","doi-asserted-by":"publisher","unstructured":"De Felice LJ (2016) A current view of serotonin transporters. https:\/\/doi.org\/10.12688\/f1000research.8384.1","DOI":"10.12688\/f1000research.8384.1"},{"key":"5103_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0303-2647(01)00137-X","volume":"62","author":"LJ DeFelice","year":"2001","unstructured":"DeFelice LJ, Adams SV, Ypey DL (2001) Single-file diffusion and neurotransmitter transporters: Hodgkin and Keynes model revisited. Biosystems 62:57\u201366","journal-title":"Biosystems"},{"key":"5103_CR28","doi-asserted-by":"publisher","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","volume":"85","author":"G Di Chiara","year":"1988","unstructured":"Di Chiara G, Imperato A (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85:5274\u20135278","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5103_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrn3125","volume":"13","author":"E Eggermann","year":"2011","unstructured":"Eggermann E, Bucurenciu I, Goswami SP, Jonas P (2011) Nanodomain coupling between ca(2)(+) channels and sensors of exocytosis at fast mammalian synapses. Nat Rev Neurosci 13:7\u201321","journal-title":"Nat Rev Neurosci"},{"key":"5103_CR30","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ceca.2011.01.005","volume":"49","author":"JM Eltit","year":"2011","unstructured":"Eltit JM, Szpyt J, Li H, Allen PD, Perez CF (2011) Reduced gain of excitation-contraction coupling in triadin-null myotubes is mediated by the disruption of FKBP12\/RyR1 interaction. Cell Calcium 49:128\u2013135","journal-title":"Cell Calcium"},{"key":"5103_CR31","doi-asserted-by":"publisher","first-page":"36116","DOI":"10.1074\/jbc.M114.615526","volume":"289","author":"JM Eltit","year":"2014","unstructured":"Eltit JM, Franzini-Armstrong C, Perez CF (2014) Amino acid residues 489-503 of dihydropyridine receptor (DHPR) beta1a subunit are critical for structural communication between the skeletal muscle DHPR complex and type 1 ryanodine receptor. J Biol Chem 289:36116\u201336124","journal-title":"J Biol Chem"},{"key":"5103_CR32","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1523\/JNEUROSCI.2796-07.2008","volume":"28","author":"K Erreger","year":"2008","unstructured":"Erreger K, Grewer C, Javitch JA, Galli A (2008) Currents in response to rapid concentration jumps of amphetamine uncover novel aspects of human dopamine transporter function. J Neurosci 28:976\u2013989","journal-title":"J Neurosci"},{"key":"5103_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00213-017-4779-2","volume":"235","author":"AA Feduccia","year":"2018","unstructured":"Feduccia AA, Holland J, Mithoefer MC (2018) Progress and promise for the MDMA drug development program. Psychopharmacology 235:561\u2013571","journal-title":"Psychopharmacology"},{"key":"5103_CR34","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1212\/WNL.50.2_Suppl_1.S43","volume":"50","author":"JM Fry","year":"1998","unstructured":"Fry JM (1998) Treatment modalities for narcolepsy. Neurology 50:S43\u2013S48","journal-title":"Neurology"},{"key":"5103_CR35","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1242\/jeb.198.10.2197","volume":"198","author":"A Galli","year":"1995","unstructured":"Galli A, DeFelice LJ, Duke BJ, Moore KR, Blakely RD (1995) Sodium-dependent norepinephrine-induced currents in norepinephrine-transporter-transfected HEK-293 cells blocked by cocaine and antidepressants. J Exp Biol 198:2197\u20132212","journal-title":"J Exp Biol"},{"key":"5103_CR36","doi-asserted-by":"publisher","first-page":"8671","DOI":"10.1073\/pnas.93.16.8671","volume":"93","author":"A Galli","year":"1996","unstructured":"Galli A, Blakely RD, DeFelice LJ (1996) Norepinephrine transporters have channel modes of conduction. Proc Natl Acad Sci U S A 93:8671\u20138676","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5103_CR37","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1085\/jgp.103.1.107","volume":"103","author":"J Garcia","year":"1994","unstructured":"Garcia J, Beam KG (1994) Measurement of calcium transients and slow calcium current in myotubes. J Gen Physiol 103:107\u2013123","journal-title":"J Gen Physiol"},{"key":"5103_CR38","first-page":"154","volume":"105","author":"RA Glennon","year":"1990","unstructured":"Glennon RA (1990) Phenylalkylamine stimulants, hallucinogens, and designer drugs. NIDA Res Monogr 105:154\u2013160","journal-title":"NIDA Res Monogr"},{"key":"5103_CR39","unstructured":"Glennon RA (1991) Discriminative stimulus properties of hallucinogens and related designer drugs. NIDA Res Monogr:25\u201344"},{"key":"5103_CR40","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0091-3057(99)00045-3","volume":"64","author":"RA Glennon","year":"1999","unstructured":"Glennon RA (1999) Arylalkylamine drugs of abuse: an overview of drug discrimination studies. Pharmacol Biochem Behav 64:251\u2013256","journal-title":"Pharmacol Biochem Behav"},{"key":"5103_CR41","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/B978-0-12-420118-7.00015-9","volume":"69","author":"RA Glennon","year":"2014","unstructured":"Glennon RA (2014) Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention. Adv Pharmacol 69:581\u2013620","journal-title":"Adv Pharmacol"},{"key":"5103_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/7854_2016_41","volume":"32","author":"RA Glennon","year":"2017","unstructured":"Glennon RA, Dukat M (2017) Structure-activity relationships of synthetic cathinones. Curr Top Behav Neurosci 32:19\u201347","journal-title":"Curr Top Behav Neurosci"},{"key":"5103_CR43","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/0091-3057(87)90164-X","volume":"26","author":"RA Glennon","year":"1987","unstructured":"Glennon RA, Yousif M, Naiman N, Kalix P (1987) Methcathinone: a new and potent amphetamine-like agent. Pharmacol Biochem Behav 26:547\u2013551","journal-title":"Pharmacol Biochem Behav"},{"key":"5103_CR44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/0091-3057(94)00348-3","volume":"50","author":"RA Glennon","year":"1995","unstructured":"Glennon RA, Young R, Martin BR, Dal Cason TA (1995) Methcathione (\u201ccat\u201d): an enantiomeric potency comparison. Pharmacol Biochem Behav 50:601\u2013606","journal-title":"Pharmacol Biochem Behav"},{"key":"5103_CR45","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0091-3057(96)00306-1","volume":"57","author":"RA Glennon","year":"1997","unstructured":"Glennon RA, Young R, Dukat M, Cheng Y (1997) Initial characterization of PMMA as a discriminative stimulus. Pharmacol Biochem Behav 57:151\u2013158","journal-title":"Pharmacol Biochem Behav"},{"key":"5103_CR46","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.pbb.2007.01.007","volume":"86","author":"RA Glennon","year":"2007","unstructured":"Glennon RA, Young R, Dukat M, Chang-Fong J, El-Zahabi M (2007) N-Methyl-1-(4-methoxyphenyl)-2-aminopropane (PMMA) and N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) produce non-identical discriminative stimuli in rats. Pharmacol Biochem Behav 86:477\u2013484","journal-title":"Pharmacol Biochem Behav"},{"key":"5103_CR47","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/00004714-200110000-00010","volume":"21","author":"J Grabowski","year":"2001","unstructured":"Grabowski J, Rhoades H, Schmitz J, Stotts A, Daruzska LA, Creson D, Moeller FG (2001) Dextroamphetamine for cocaine-dependence treatment: a double-blind randomized clinical trial. J Clin Psychopharmacol 21:522\u2013526","journal-title":"J Clin Psychopharmacol"},{"key":"5103_CR48","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1016\/S0021-9258(17)37256-3","volume":"269","author":"H Gu","year":"1994","unstructured":"Gu H, Wall SC, Rudnick G (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem 269:7124\u20137130","journal-title":"J Biol Chem"},{"key":"5103_CR49","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1046\/j.1471-4159.1996.66010243.x","volume":"66","author":"GA Gudelsky","year":"1996","unstructured":"Gudelsky GA, Nash JF (1996) Carrier-mediated release of serotonin by 3,4-methylenedioxymethamphetamine: implications for serotonin-dopamine interactions. J Neurochem 66:243\u2013249","journal-title":"J Neurochem"},{"key":"5103_CR50","first-page":"318","volume":"27","author":"H Halbach","year":"1979","unstructured":"Halbach H (1979) Khat\u2014the problem today. NIDA Res Monogr 27:318\u2013319","journal-title":"NIDA Res Monogr"},{"key":"5103_CR51","doi-asserted-by":"publisher","first-page":"37052","DOI":"10.1074\/jbc.M305514200","volume":"278","author":"LK Henry","year":"2003","unstructured":"Henry LK, Adkins EM, Han Q, Blakely RD (2003) Serotonin and cocaine-sensitive inactivation of human serotonin transporters by methanethiosulfonates targeted to transmembrane domain I. J Biol Chem 278:37052\u201337063","journal-title":"J Biol Chem"},{"key":"5103_CR52","volume-title":"Ion channels of excitable membranes, 3rd edn","author":"B Hille","year":"2001","unstructured":"Hille B (2001) Ion channels of excitable membranes, 3rd edn. Sinauer, Sunderland"},{"key":"5103_CR53","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1021\/acschemneuro.5b00277","volume":"7","author":"AF Hoffman","year":"2016","unstructured":"Hoffman AF, Spivak CE, Lupica CR (2016) Enhanced dopamine release by dopamine transport inhibitors described by a restricted diffusion model and fast-scan cyclic voltammetry. ACS Chem Neurosci 7:700\u2013709","journal-title":"ACS Chem Neurosci"},{"key":"5103_CR54","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.pharmthera.2017.10.022","volume":"182","author":"L Hondebrink","year":"2018","unstructured":"Hondebrink L, Zwartsen A, Westerink RHS (2018) Effect fingerprinting of new psychoactive substances (NPS): what can we learn from in vitro data? Pharmacol Ther 182:193\u2013224","journal-title":"Pharmacol Ther"},{"key":"5103_CR55","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.euroneuro.2015.12.010","volume":"26","author":"BA Hutsell","year":"2016","unstructured":"Hutsell BA, Baumann MH, Partilla JS, Banks ML, Vekariya R, Glennon RA, Negus SS (2016) Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats. Eur Neuropsychopharmacol 26:288\u2013297","journal-title":"Eur Neuropsychopharmacol"},{"key":"5103_CR56","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nn920","volume":"5","author":"SL Ingram","year":"2002","unstructured":"Ingram SL, Prasad BM, Amara SG (2002) Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat Neurosci 5:971\u2013978","journal-title":"Nat Neurosci"},{"key":"5103_CR57","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/0143-4160(94)90011-6","volume":"15","author":"E Jaimovich","year":"1994","unstructured":"Jaimovich E, Rojas E (1994) Intracellular Ca2+ transients induced by high external K+ and tetracaine in cultured rat myotubes. Cell Calcium 15:356\u2013368","journal-title":"Cell Calcium"},{"key":"5103_CR58","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1016\/j.neuropharm.2007.03.004","volume":"52","author":"CE John","year":"2007","unstructured":"John CE, Jones SR (2007) Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology 52:1596\u20131605","journal-title":"Neuropharmacology"},{"key":"5103_CR59","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0364-7722(82)80106-9","volume":"6","author":"P Kalix","year":"1982","unstructured":"Kalix P (1982) The amphetamine-like releasing effect of the alkaloid (\u2212)cathinone on rat nucleus accumbens and rabbit caudate nucleus. Prog Neuro-Psychopharmacol Biol Psychiatry 6:43\u201349","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5103_CR60","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1016\/0006-2952(86)90380-1","volume":"35","author":"P Kalix","year":"1986","unstructured":"Kalix P, Glennon RA (1986) Further evidence for an amphetamine-like mechanism of action of the alkaloid cathinone. Biochem Pharmacol 35:3015\u20133019","journal-title":"Biochem Pharmacol"},{"key":"5103_CR61","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nsmb.2816","volume":"21","author":"K Kazmier","year":"2014","unstructured":"Kazmier K, Sharma S, Quick M, Islam SM, Roux B, Weinstein H, Javitch JA, McHaourab HS (2014) Conformational dynamics of ligand-dependent alternating access in LeuT. Nat Struct Mol Biol 21:472\u2013479","journal-title":"Nat Struct Mol Biol"},{"key":"5103_CR62","first-page":"322","volume":"27","author":"J Knoll","year":"1979","unstructured":"Knoll J (1979) Studies on the central effects of (\u2212)cathinone. NIDA Res Monogr 27:322\u2013323","journal-title":"NIDA Res Monogr"},{"key":"5103_CR63","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1021\/acschemneuro.5b00006","volume":"6","author":"R Kolanos","year":"2015","unstructured":"Kolanos R, Partilla JS, Baumann MH, Hutsell BA, Banks ML, Negus SS, Glennon RA (2015) Stereoselective actions of methylenedioxypyrovalerone (MDPV) to inhibit dopamine and norepinephrine transporters and facilitate intracranial self-stimulation in rats. ACS Chem Neurosci 6:771\u2013777","journal-title":"ACS Chem Neurosci"},{"key":"5103_CR64","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1016\/S0006-3495(96)79506-1","volume":"71","author":"F Lin","year":"1996","unstructured":"Lin F, Lester HA, Mager S (1996) Single-channel currents produced by the serotonin transporter and analysis of a mutation affecting ion permeation. Biophys J 71:3126\u20133135","journal-title":"Biophys J"},{"key":"5103_CR65","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1074\/jbc.M304755200","volume":"279","author":"CJ Loland","year":"2004","unstructured":"Loland CJ, Granas C, Javitch JA, Gether U (2004) Identification of intracellular residues in the dopamine transporter critical for regulation of transporter conformation and cocaine binding. J Biol Chem 279:3228\u20133238","journal-title":"J Biol Chem"},{"key":"5103_CR66","first-page":"1","volume":"32","author":"BK Madras","year":"2017","unstructured":"Madras BK (2017) The growing problem of new psychoactive substances (NPS). Curr Top Behav Neurosci 32:1\u201318","journal-title":"Curr Top Behav Neurosci"},{"key":"5103_CR67","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/0896-6273(94)90337-9","volume":"12","author":"S Mager","year":"1994","unstructured":"Mager S, Min C, Henry DJ, Chavkin C, Hoffman BJ, Davidson N, Lester HA (1994) Conducting states of a mammalian serotonin transporter. Neuron 12:845\u2013859","journal-title":"Neuron"},{"key":"5103_CR68","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.biopsych.2012.05.032","volume":"72","author":"JJ Mariani","year":"2012","unstructured":"Mariani JJ, Pavlicova M, Bisaga A, Nunes EV, Brooks DJ, Levin FR (2012) Extended-release mixed amphetamine salts and topiramate for cocaine dependence: a randomized controlled trial. Biol Psychiatry 72:950\u2013956","journal-title":"Biol Psychiatry"},{"key":"5103_CR69","unstructured":"Mattson ME (2013) Emergency department visits involving methamphetamine: 2007 to 2011 The CBHSQ Report, Rockville, MD, pp 1\u20137"},{"key":"5103_CR70","first-page":"482","volume":"2","author":"E Mignot","year":"1996","unstructured":"Mignot E (1996) Perspectives in narcolepsy research and therapy. Curr Opin Pulm Med 2:482\u2013487","journal-title":"Curr Opin Pulm Med"},{"key":"5103_CR71","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1124\/jpet.110.166595","volume":"334","author":"KS Murnane","year":"2010","unstructured":"Murnane KS, Fantegrossi WE, Godfrey JR, Banks ML, Howell LL (2010) Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys. J Pharmacol Exp Ther 334:642\u2013650","journal-title":"J Pharmacol Exp Ther"},{"key":"5103_CR72","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1038\/npp.2014.322","volume":"40","author":"SS Negus","year":"2015","unstructured":"Negus SS, Henningfield J (2015) Agonist medications for the treatment of cocaine use disorder. Neuropsychopharmacology 40:1815\u20131825","journal-title":"Neuropsychopharmacology"},{"key":"5103_CR73","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1124\/pr.112.007419","volume":"66","author":"SS Negus","year":"2014","unstructured":"Negus SS, Miller LL (2014) Intracranial self-stimulation to evaluate abuse potential of drugs. Pharmacol Rev 66:869\u2013917","journal-title":"Pharmacol Rev"},{"key":"5103_CR74","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/S0140-6736(16)00205-1","volume":"387","author":"M Nuijten","year":"2016","unstructured":"Nuijten M, Blanken P, van de Wetering B, Nuijen B, van den Brink W, Hendriks VM (2016) Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial. Lancet 387:2226\u20132234","journal-title":"Lancet"},{"key":"5103_CR75","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF00212770","volume":"95","author":"R Oberlender","year":"1988","unstructured":"Oberlender R, Nichols DE (1988) Drug discrimination studies with MDMA and amphetamine. Psychopharmacology 95:71\u201376","journal-title":"Psychopharmacology"},{"key":"5103_CR76","unstructured":"Overton DA (1991) A historical perspective on drug discrimination. NIDA Res Monogr:5\u201324"},{"key":"5103_CR77","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1113\/jphysiol.2013.259051","volume":"592","author":"A Penmatsa","year":"2014","unstructured":"Penmatsa A, Gouaux E (2014) How LeuT shapes our understanding of the mechanisms of sodium-coupled neurotransmitter transporters. J Physiol 592:863\u2013869","journal-title":"J Physiol"},{"key":"5103_CR78","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jsat.2010.08.012","volume":"40","author":"C Perez-Mana","year":"2011","unstructured":"Perez-Mana C, Castells X, Vidal X, Casas M, Capella D (2011) Efficacy of indirect dopamine agonists for psychostimulant dependence: a systematic review and meta-analysis of randomized controlled trials. J Subst Abus Treat 40:109\u2013122","journal-title":"J Subst Abus Treat"},{"key":"5103_CR79","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s12576-009-0069-z","volume":"60","author":"E Rios","year":"2010","unstructured":"Rios E (2010) The cell boundary theorem: a simple law of the control of cytosolic calcium concentration. J Physiol Sci 60:81\u201384","journal-title":"J Physiol Sci"},{"key":"5103_CR80","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ejphar.2003.08.054","volume":"479","author":"RB Rothman","year":"2003","unstructured":"Rothman RB, Baumann MH (2003) Monoamine transporters and psychostimulant drugs. Eur J Pharmacol 479:23\u201340","journal-title":"Eur J Pharmacol"},{"key":"5103_CR81","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.2174\/156802606778249766","volume":"6","author":"RB Rothman","year":"2006","unstructured":"Rothman RB, Baumann MH (2006) Therapeutic potential of monoamine transporter substrates. Curr Top Med Chem 6:1845\u20131859","journal-title":"Curr Top Med Chem"},{"key":"5103_CR82","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/syn.890140106","volume":"14","author":"RB Rothman","year":"1993","unstructured":"Rothman RB, Lewis B, Dersch C, Xu H, Radesca L, de Costa BR, Rice KC, Kilburn RB, Akunne HC, Pert A (1993) Identification of a GBR12935 homolog, LR1111, which is over 4,000-fold selective for the dopamine transporter, relative to serotonin and norepinephrine transporters. Synapse 14:34\u201339","journal-title":"Synapse"},{"key":"5103_CR83","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/(SICI)1098-2396(20000301)35:3<222::AID-SYN7>3.0.CO;2-K","volume":"35","author":"RB Rothman","year":"2000","unstructured":"Rothman RB, Partilla JS, Baumann MH, Dersch CM, Carroll FI, Rice KC (2000) Neurochemical neutralization of methamphetamine with high-affinity nonselective inhibitors of biogenic amine transporters: a pharmacological strategy for treating stimulant abuse. Synapse 35:222\u2013227","journal-title":"Synapse"},{"key":"5103_CR84","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1124\/jpet.103.053975","volume":"307","author":"RB Rothman","year":"2003","unstructured":"Rothman RB, Vu N, Partilla JS, Roth BL, Hufeisen SJ, Compton-Toth BA, Birkes J, Young R, Glennon RA (2003) In vitro characterization of ephedrine-related stereoisomers at biogenic amine transporters and the receptorome reveals selective actions as norepinephrine transporter substrates. J Pharmacol Exp Ther 307:138\u2013145","journal-title":"J Pharmacol Exp Ther"},{"key":"5103_CR85","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/jpet.111.188946","volume":"341","author":"RB Rothman","year":"2012","unstructured":"Rothman RB, Partilla JS, Baumann MH, Lightfoot-Siordia C, Blough BE (2012) Studies of the biogenic amine transporters. 14. Identification of low-efficacy \u201cpartial\u201d substrates for the biogenic amine transporters. J Pharmacol Exp Ther 341:251\u2013262","journal-title":"J Pharmacol Exp Ther"},{"key":"5103_CR86","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ceca.2014.04.003","volume":"56","author":"I Ruchala","year":"2014","unstructured":"Ruchala I, Cabra V, Solis E Jr, Glennon RA, De Felice LJ, Eltit JM (2014) Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels. Cell Calcium 56:25\u201333","journal-title":"Cell Calcium"},{"key":"5103_CR87","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1016\/S0021-9258(17)40535-7","volume":"252","author":"G Rudnick","year":"1977","unstructured":"Rudnick G (1977) Active transport of 5-hydroxytryptamine by plasma membrane vesicles isolated from human blood platelets. J Biol Chem 252:2170\u20132174","journal-title":"J Biol Chem"},{"key":"5103_CR88","doi-asserted-by":"publisher","first-page":"4739","DOI":"10.1021\/bi00615a021","volume":"17","author":"G Rudnick","year":"1978","unstructured":"Rudnick G, Nelson PJ (1978) Platelet 5-hydroxytryptamine transport, an electroneutral mechanism coupled to potassium. Biochemistry 17:4739\u20134742","journal-title":"Biochemistry"},{"key":"5103_CR89","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1111\/bph.13043","volume":"172","author":"F Sakloth","year":"2015","unstructured":"Sakloth F, Kolanos R, Mosier PD, Bonano JS, Banks ML, Partilla JS, Baumann MH, Negus SS, Glennon RA (2015) Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues. Br J Pharmacol 172:2210\u20132218","journal-title":"Br J Pharmacol"},{"key":"5103_CR90","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1124\/mol.115.101394","volume":"89","author":"W Sandtner","year":"2016","unstructured":"Sandtner W, Stockner T, Hasenhuetl PS, Partilla JS, Seddik A, Zhang YW, Cao J, Holy M, Steinkellner T, Rudnick G, Baumann MH, Ecker GF, Newman AH, Sitte HH (2016) Binding mode selection determines the action of ecstasy homologs at monoamine transporters. Mol Pharmacol 89:165\u2013175","journal-title":"Mol Pharmacol"},{"key":"5103_CR91","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0014-2999(73)90228-8","volume":"21","author":"MD Schechter","year":"1973","unstructured":"Schechter MD, Rosecrans JA (1973) D-amphetamine as a discriminative cue: drugs with similar stimulus properties. Eur J Pharmacol 21:212\u2013216","journal-title":"Eur J Pharmacol"},{"key":"5103_CR92","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1074\/jbc.M111.304261","volume":"287","author":"K Schicker","year":"2012","unstructured":"Schicker K, Uzelac Z, Gesmonde J, Bulling S, Stockner T, Freissmuth M, Boehm S, Rudnick G, Sitte HH, Sandtner W (2012) Unifying concept of serotonin transporter-associated currents. J Biol Chem 287:438\u2013445","journal-title":"J Biol Chem"},{"key":"5103_CR93","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/sj.mp.4000421","volume":"3","author":"P Seeman","year":"1998","unstructured":"Seeman P, Madras BK (1998) Anti-hyperactivity medication: methylphenidate and amphetamine. Mol Psychiatry 3:386\u2013396","journal-title":"Mol Psychiatry"},{"key":"5103_CR94","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/jnc.12808","volume":"131","author":"CA Siciliano","year":"2014","unstructured":"Siciliano CA, Calipari ES, Jones SR (2014) Amphetamine potency varies with dopamine uptake rate across striatal subregions. J Neurochem 131:348\u2013355","journal-title":"J Neurochem"},{"key":"5103_CR95","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1523\/JNEUROSCI.2604-17.2017","volume":"38","author":"CA Siciliano","year":"2018","unstructured":"Siciliano CA, Saha K, Calipari ES, Fordahl SC, Chen R, Khoshbouei H, Jones SR (2018) Amphetamine reverses escalated cocaine intake via restoration of dopamine transporter conformation. J Neurosci 38:484\u2013497","journal-title":"J Neurosci"},{"key":"5103_CR96","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1038\/npp.2017.98","volume":"42","author":"E Solis Jr","year":"2017","unstructured":"Solis E Jr, Partilla JS, Sakloth F, Ruchala I, Schwienteck KL, De Felice LJ, Eltit JM, Glennon RA, Negus SS, Baumann MH (2017) N-Alkylated analogs of 4-methylamphetamine (4-MA) differentially affect monoamine transporters and abuse liability. Neuropsychopharmacology 42:1950\u20131961","journal-title":"Neuropsychopharmacology"},{"key":"5103_CR97","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1523\/JNEUROSCI.17-03-00960.1997","volume":"17","author":"MS Sonders","year":"1997","unstructured":"Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, Amara SG (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17:960\u2013974","journal-title":"J Neurosci"},{"key":"5103_CR98","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S0006-3495(96)79616-9","volume":"70","author":"A Su","year":"1996","unstructured":"Su A, Mager S, Mayo SL, Lester HA (1996) A multi-substrate single-file model for ion-coupled transporters. Biophys J 70:762\u2013777","journal-title":"Biophys J"},{"key":"5103_CR99","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1124\/jpet.115.229559","volume":"356","author":"JA Suyama","year":"2016","unstructured":"Suyama JA, Sakloth F, Kolanos R, Glennon RA, Lazenka MF, Negus SS, Banks ML (2016) Abuse-related neurochemical effects of para-substituted methcathinone analogs in rats: microdialysis studies of nucleus accumbens dopamine and serotonin. J Pharmacol Exp Ther 356:182\u2013190","journal-title":"J Pharmacol Exp Ther"},{"key":"5103_CR100","doi-asserted-by":"publisher","first-page":"15794","DOI":"10.1073\/pnas.1313898110","volume":"110","author":"MR Tadross","year":"2013","unstructured":"Tadross MR, Tsien RW, Yue DT (2013) Ca2+ channel nanodomains boost local Ca2+ amplitude. Proc Natl Acad Sci U S A 110:15794\u201315799","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5103_CR101","unstructured":"United Nations Office on Drugs and Crime, World Drug Report (2017) United Nations publication, Sales No. E.17.XI.6"},{"key":"5103_CR102","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0376-8716(98)00063-5","volume":"51","author":"RA Wise","year":"1998","unstructured":"Wise RA (1998) Drug-activation of brain reward pathways. Drug Alcohol Depend 51:13\u201322","journal-title":"Drug Alcohol Depend"},{"key":"5103_CR103","doi-asserted-by":"crossref","unstructured":"Young R (2009) Drug discrimination. In: nd, Buccafusco JJ (ed) Methods of Behavior Analysis in Neuroscience (Frontiers in Neuroscience), Boca Raton, FL","DOI":"10.1201\/NOE1420052343.ch3"},{"key":"5103_CR104","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature09971","volume":"474","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Terry DS, Shi L, Quick M, Weinstein H, Blanchard SC, Javitch JA (2011) Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue. Nature 474:109\u2013113","journal-title":"Nature"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5103-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-018-5103-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-5103-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T06:35:52Z","timestamp":1694068552000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-018-5103-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,17]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["5103"],"URL":"https:\/\/doi.org\/10.1007\/s00213-018-5103-5","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,17]]},"assertion":[{"value":"7 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}